---
title: "C&S and Bloomage Biotech's joint venture biotechnology company has been deregistered"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/261376805.md"
description: "According to Tianyancha's business information, recently, Beijing Bloomage Biotech Co., Ltd. changed its registration status from active to canceled. Previously, the company had issued a simple cancellation announcement. The company was established in September 2021, with Zhao Ming as the legal representative, a registered capital of 10 million RMB, and its business scope includes the sale of paper products, daily necessities, sanitary products, cosmetics, etc., with C&S and Bloomage Biotech holding 51% and 49% of the shares, respectively"
datetime: "2025-10-16T06:41:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/261376805.md)
  - [en](https://longbridge.com/en/news/261376805.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/261376805.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/261376805.md) | [繁體中文](https://longbridge.com/zh-HK/news/261376805.md)


# C&S and Bloomage Biotech's joint venture biotechnology company has been deregistered

According to Tianyancha's business information, recently, Beijing Bloomage Biotech Co., Ltd. changed its registration status from active to canceled. Previously, the company had issued a simple cancellation announcement. The company was established in September 2021, with Zhao Ming as the legal representative, a registered capital of 10 million RMB, and its business scope includes the sale of paper products, daily necessities, sanitary products, cosmetics, etc., with C&S and Bloomage Biotech holding 51% and 49% of the shares, respectively

### Related Stocks

- [Bloomage Biotech (688363.CN)](https://longbridge.com/en/quote/688363.CN.md)
- [C&S (002511.CN)](https://longbridge.com/en/quote/002511.CN.md)

## Related News & Research

- [On the Future of Species: Book explores power to design future lifeforms](https://longbridge.com/en/news/278431347.md)
- [RFK Jr.'s vaccine advisers drop proposal to revisit COVID-19 shot - Wapo](https://longbridge.com/en/news/278689184.md)
- [Jiangsu Hengrui Pharmaceuticals Gets China Nod for Two Anti-Tumor Injectables](https://longbridge.com/en/news/278349440.md)
- [The Naderi Center Introduces Advanced PRF Injections Using the EZPRF Platform](https://longbridge.com/en/news/278879007.md)
- [Vox Royalty to Court Institutional Investors at Roth Growth Conference](https://longbridge.com/en/news/278572258.md)